Transcutaneous Immunization System Using a Hydrotropic Formulation Induces a Potent Antigen-Specific Antibody Response

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Takatani Nakase, Tomoka ^a   Tokuyama, Erika ^a   Komai, Megumi ^a   Takahashi, Koichi ^a  

^a MUKOGAWA WOMEN'S UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CHOLERA TOXIN; IMMUNOGLOBULIN E; INTERLEUKIN 2; LIPOPOLYSACCHARIDE; LIPOSOME; LYSOZYME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROPYLENE GLYCOL MONOCAPRYLATE; SALICYLATE SODIUM; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; WATER;

ANAPHYLAXIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN ANTIBODY REACTION; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CELL ACTIVATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUBILITY; FEMALE; IMMUNIZATION; IN VITRO STUDY; MOUSE; NONHUMAN; TRANSCUTANEOUS IMMUNIZATION;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIBODIES; ANTIGENS; CAPRYLATES; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FLUORESCEIN-5-ISOTHIOCYANATE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; IMMUNIZATION; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; MICROSCOPY, FLUORESCENCE; MURAMIDASE; PROPYLENE GLYCOL; SKIN; SODIUM SALICYLATE; SOLUBILITY;

EID: 84868149469     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047980     Document Type: Article

References (38)

1. Bal SM, Ding Z, van Riet E, Jiskoot W, Bouwstra JA, (2010) Advances in transcutaneous vaccine delivery: do all ways lead to Rome? J Control Release 148: 266-82.
2. Metz M, Siebenhaar F, Maurer M, (2008) Mast cell functions in the innate skin immune system. Immunobiology 213: 251-60.
3. Sugita K, Kabashima K, Atarashi K, Shimauchi T, Kobayashi M, et al. (2007) Innate immunity mediated by epidermal keratinocytes promotes acquired immunity involving Langerhans cells and T cells in the skin. Clin Exp Immunol 147: 176-83.
4. Slütter B, Bal SM, Ding Z, Jiskoot W, Bouwstra JA, (2011) Adjuvant effect of cationic liposomes and CpG depends on administration route. J Control Release 154: 123-30.
5. Wilson-Welder JH, Torres MP, Kipper MJ, Mallapragada SK, Wannemuehler MJ, et al. (2009) Vaccine adjuvants: current challenges and future approaches. J Pharm Sci 98: 1278-316.
6. Singh M, O'Hagan DT, (2002) Recent advances in vaccine adjuvants. Pharm Res 19: 715-28.
7. Hunter RL, (2002) Overview of vaccine adjuvants: present and future. Vaccine 20: S7-12.
8. Alving CR, (2002) Design and selection of vaccine adjuvants: animal models and human trials. Vaccine 20: S56-64.
9. Schijns VE, (2000) Immunological concepts of vaccine adjuvant activity. Curr Opin Immunol 12: 456-63.
10. Glenn GM, Scharton-Kersten T, Vassell R, Matyas GR, Alving CR, (1999) Transcutaneous immunization with bacterial ADP-ribosylating exotoxins as antigens and adjuvants. Infect Immun 67: 1100-6.
11. Inoue J, Yotsumoto S, Sakamoto T, Tsuchiya S, Aramaki Y, (2005) Changes in immune responses to antigen applied to tape-stripped skin with CpG-oligodeoxynucleotide in mice. J Control Release 108: 294-305.
12. Wood LC, Jackson SM, Elias PM, Grunfeld C, Feingold KR, (1992) Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest 90: 482-7.
13. Li N, Peng LH, Chen X, Nakagawa S, Gao JQ, (2011) Transcutaneous vaccines: novel advances in technology and delivery for overcoming the barriers. Vaccine 29: 6179-90.
14. Gonzalez-Rodriguez ML, Rabasco AM, (2011) Charged liposomes as carriers to enhance the permeation through the skin. Expert Opin Drug Deliv 8: 857-71.
15. Pierre MB, Dos Santos Miranda Costa I, (2011) Liposomal systems as drug delivery vehicles for dermal and transdermal applications. Arch Dermatol Res. 303: 607-21.
16. Matsuo K, Ishii Y, Quan YS, Kamiyama F, Mukai Y, et al. (2011) Transcutaneous vaccination using a hydrogel patch induces effective immune responses to tetanus and diphtheria toxoid in hairless rat. J Control Release 149: 15-20.
17. Huang Y, Yu F, Park YS, Wang J, Shin MC, et al. (2010) Co-administration of protein drugs with gold nanoparticles to enable percutaneous delivery. Biomaterials 31: 9086-91.
18. Ibrahim SA, Li SK, (2010) Efficiency of fatty acids as chemical penetration enhancers: mechanisms and structure enhancement relationship. Pharm Res 27: 115-25.
19. Williams AC, Barry BW, (2004) Penetration enhancers. Adv Drug Deliv Rev 56: 603-18.
20. Takahashi K, Sakano H, Yoshida M, Numata N, Mizuno N, (2001) Characterization of the influence of polyol fatty acid esters on the permeation of diclofenac through rat skin. J Control Release 73: 351-8.
21. Skountzou I, Quan FS, Jacob J, Compans RW, Kang SM, (2006) Transcutaneous immunization with inactivated influenza virus induces protective immune responses. Vaccine 24: 6110-9.
22. Takahashi K, Komai M, Kinoshita N, Nakamura E, Hou XL, et al. (2011) Application of hydrotropy to transdermal formulations: hydrotropic solubilization of polyol fatty acid monoesters in water and enhancement effect on skin permeation of 5-FU. J Pharm Pharmacol 63: 1008-14.
23. Evstigneev MP, Evstigneev VP, Santiago AA, Davies DB, (2006) Effect of a mixture of caffeine and nicotinamide on the solubility of vitamin (B2) in aqueous solution. Eur J Pharm Sci 28: 59-66.
24. Agrawal S, Pancholi SS, Jain NK, Agrawal GP, (2004) Hydrotropic solubilization of nimesulide for parenteral administration. Int J Pharm 274: 149-55.
25. McKee R, (1946) Use of Hydrotrope Solution in Industries. Ind Eng Chem 38: 382-7.
26. Neuberug C, (1916) Hydrotropy. Biochem Z 76: 107-76.
27. Tsujikawa K, Yayama K, Hayashi T, Matsushita H, Yamaguchi T, et al. (2007) Hypertension and dysregulated proinflammatory cytokine production in receptor activity-modifying protein 1-deficient mice. Proc Natl Acad Sci U S A 104: 16702-7.
28. Lutz MB, Kukutsch N, Ogilvie AL, Rossner S, Koch F, et al. (1999) An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 223: 77-92.
29. Kataoka H, Shinohara Y, Takatani T, Mizuta A, Tsuda Y, et al. (1999) Detection of anaphylactic reaction in the percutaneously sensitized mouse using the AW method. Biol Pharm Bull 22: 896-9.
30. Kataoka H, Tsuda A, Tsuda Y, Baba A, Yoshida H, et al. (1997) A novel method for induction and detection of anaphylactic reaction using the mouse abdominal wall (AW method). Biol Pharm Bull 20: 714-6.
31. Shive CL, Hofstetter H, Arredondo L, Shaw C, Forsthuber TG, (2000) The enhanced antigen-specific production of cytokines induced by pertussis toxin is due to clonal expansion of T cells and not to altered effector functions of long-term memory cells. Eur J Immunol 30: 2422-31.
32. Agren LC, Ekman L, Lowenadler B, Nedrud JG, Lycke NY, (1999) Adjuvanticity of the cholera toxin A1-based gene fusion protein, CTA1-DD, is critically dependent on the ADP-ribosyltransferase and Ig-binding activity. J Immunol 162: 2432-40.
33. Abramson SB, Leszczynska-Piziak J, Clancy RM, Philips M, Weissmann G, (1994) Inhibition of neutrophil function by aspirin-like drugs (NSAIDS): requirement for assembly of heterotrimeric G proteins in bilayer phospholipid. Biochem Pharmacol 47: 563-72.
34. Ohl L, Mohaupt M, Czeloth N, Hintzen G, Kiafard Z, et al. (2004) CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 21: 279-88.
35. Hsia J, Tang T, Parrott M, Rogalla K, (1994) Augmentation of the immune response to influenza vaccine by acetylsalicylic acid: a clinical trial in a geriatric population. Methods Find Exp Clin Pharmacol 16: 677-83.
36. Beck L, Spiegelberg HL, (1989) The polyclonal and antigen-specific IgE and IgG subclass response of mice injected with ovalbumin in alum or complete Freund's adjuvant. Cell Immunol 123: 1-8.
37. Nestle FO, Di Meglio P, Qin JZ, Nickoloff BJ, (2009) Skin immune sentinels in health and disease. Nat Rev Immunol 9: 679-91.
38. Clark RA, (2010) Skin-resident T cells: the ups and downs of on site immunity. J Invest Dermatol 130: 362-70.